FocusStroke

Neuroprotective therapies: Preclinical reproducibility is only part of the problem

Science Translational Medicine  05 Aug 2015:
Vol. 7, Issue 299, pp. 299fs32
DOI: 10.1126/scitranslmed.aac9412

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Among the many unknowns in the translational path to developing drugs for acute stroke, addressing the reproducibility of preclinical data is only one piece of a multifaceted and incomplete puzzle (Llovera et al., this issue).

View Full Text